Latest Financial Results News

Bank of Queensland reports a 12% rise in cash earnings for FY25 despite a 53% drop in statutory profit due to one-off impairments and restructuring. The bank’s strategic pivot towards commercial lending and digital transformation underpins improved operational performance and shareholder returns.

Sheffield Resources achieved a record quarterly concentrate production at its Thunderbird mine but faces subdued zircon sales due to challenging market conditions in China, withholding December quarter guidance.

Bank of Queensland reported a 4% increase in revenues to $1.668 billion for FY25, yet profits after tax fell sharply by 53% to $133 million. Despite the profit decline, the bank declared a fully franked 20 cent dividend for the full year.

Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.

BKI Investment Company Limited reported a steady financial performance for FY2025, raising its ordinary dividend by 1% to 7.90 cents per share. The company remains confident in maintaining dividends in FY2026, supported by a diversified portfolio and positive economic outlook.

Aussie Broadband reported robust FY25 results with nearly $1.2 billion revenue and signed a transformative six-year wholesale agreement, setting the stage for ambitious growth through FY28.

Paladin Energy reports a record uranium production quarter at its Langer Heinrich Mine alongside a robust engineering review of its Patterson Lake South Project, supported by a successful A$300 million equity raise.

Mitchell Services Limited delivered a robust Q1 FY26 performance, marked by a 68% jump in EBITDA and a dramatic 93% reduction in net debt. The company’s strategic investment in a decarbonisation joint venture signals a forward-looking growth trajectory.

Cryosite Limited reports a strong start to FY26 with a 22% revenue increase and a strategic warehouse acquisition that doubles capacity, positioning the company for sustained growth in clinical trial logistics.

Hydrix Limited will have its trading suspension lifted on 13 October 2025 following the release of its audited financial statements for FY2025. Investors await clarity on the company’s financial health as it returns to the ASX.

Pacific Smiles Group Limited has issued a Target’s Statement endorsing Beam Dental Bidco’s $2.20 per share off-market takeover bid. The Independent Expert deems the offer fair and reasonable, and the Independent Board Committee urges shareholders to accept, barring a superior proposal.

Medical Developments International reported a strong start to FY26 with significant revenue growth driven by increased Penthrox volumes and pricing improvements in Australia, alongside steady European demand and progress on paediatric label approvals.